The role of generative language systems in increasing patient awareness of colon cancer screening.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
14 Aug 2024
Historique:
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 14 8 2024
Statut: aheadofprint

Résumé

This study aims to evaluate the effectiveness of ChatGPT (Chat Generative Pretrained Transformer) in answering patients' questions about colorectal cancer (CRC) screening, with the ultimate goal of enhancing patients' awareness and adherence to national screening programs. 15 questions on CRC screening were posed to ChatGPT4. The answers were rated by 20 gastroenterology experts and 20 non-experts in three domains (accuracy, completeness, and comprehensibility), and by 100 patients in three dichotomic domains (completeness, comprehensibility and trustability). According to expert rating, the mean accuracy score was 4.8±1.1 on a scale ranging from 1 to 6. Men completeness score was 2.1±0.7 and mean comprehensibility score was 2.8±0.4 on a scale ranging from 1 to 3. Overall, accuracy (4.8±1.1 vs 5.6±0.7, P<0.001) and completeness (2.1±0.7 vs 2.7±0.4, P<0.001) scores were significantly lower for expert compared to non-expert, while comprehensibility was comparable among the two groups (2.7±0.4 vs 2.8±0.3, P=0.546). Patients rated all questions as complete, comprehensible and trustable in 97 to 100% of cases. ChatGPT shows good performance with the potential to enhance awareness about CRC and improve screening outcomes. Generative language systems may be further improved after proper training in accordance with scientific evidence and current guidelines.

Identifiants

pubmed: 39142348
doi: 10.1055/a-2388-6084
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

YM: Olympus (consulting, device loan, speaking honorarium); Cybernet System Corp. (loyalty). All the other authors have no proprietary, financial, professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of this manuscript.

Auteurs

Marcello Maida (M)

Department of Medicine and Surgery, Kore University of Enna, Enna, Italy.

Daryl Ramai (D)

Gastroenterology and Hepatology, The University of Utah School of Medicine, Salt Lake City, United States.

Yuichi Mori (Y)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.

Mário Dinis-Ribeiro (M)

Porto Comprehensive Cancer Center & RISE@CI-IPO, Porto University Hospital, Porto, Portugal.
Gastroenterology Department, Francisco Gentil Portuguese Institute for Oncology of Porto, Porto, Portugal.

Antonio Facciorusso (A)

Department of Medical Sciences, University of Foggia, Foggia, Italy.

Cesare Hassan (C)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Endoscopy Unit, IRCCS Humanitas Research Hospital, Pieve Emanuele, Italy.

Classifications MeSH